The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Mullen James C since year 2005.
The trader's CIK number is 1226288.
At the time of this reporting, Mullen James C is the CEO & President of Biogen Idec Inc .
(stock ticker symbol BIIB).
See this page for all insider trading activities at Biogen Idec Inc .
Stock purchases, sales, and option exercises reported by insider Mullen James C since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-04-15
BIIB
Biogen Idec Inc
Option Exercise
12,800
44.59
570,752
2008-04-15
BIIB
Biogen Idec Inc
Sale
12,800
64.95
831,360
2008-04-11
BIIB
Biogen Idec Inc
Sale
195,162
64.83
12,652,056
2008-04-11
BIIB
Biogen Idec Inc
Sale
102,019
64.57
6,587,248
2008-04-11
BIIB
Biogen Idec Inc
Sale
121,157
64.39
7,801,061
2008-04-11
BIIB
Biogen Idec Inc
Sale
73,927
64.17
4,744,018
2008-04-11
BIIB
Biogen Idec Inc
Option Exercise
745,750
42.75
31,880,812
2008-04-14
BIIB
Biogen Idec Inc
Sale
200
64.95
12,990
2008-04-14
BIIB
Biogen Idec Inc
Option Exercise
200
44.59
8,918
2008-04-11
BIIB
Biogen Idec Inc
Sale
56,170
65.38
3,672,139
2008-04-11
BIIB
Biogen Idec Inc
Sale
197,315
65.09
12,843,145
2008-02-07
BIIB
Biogen Idec Inc
Option Exercise
26,667
.00
0
2007-02-07
BIIB
Biogen Idec Inc
Option Exercise
26,667
.00
0
2006-11-27
BIIB
Biogen Idec Inc
Option Exercise
12,500
36.09
451,125
2006-11-27
BIIB
Biogen Idec Inc
Sale
12,500
50.99
637,336
2006-11-20
BIIB
Biogen Idec Inc
Option Exercise
159,000
36.09
5,738,310
2006-11-20
BIIB
Biogen Idec Inc
Sale
159,000
51.25
8,148,580
2006-11-17
BIIB
Biogen Idec Inc
Option Exercise
70,123
36.09
2,530,739
2006-11-16
BIIB
Biogen Idec Inc
Option Exercise
229,877
35.76
8,219,252
2006-11-17
BIIB
Biogen Idec Inc
Sale
70,123
49.95
3,502,643
2006-11-16
BIIB
Biogen Idec Inc
Sale
229,877
49.96
11,484,080
2006-04-28
BIIB
Biogen Idec Inc
Option Exercise
8,675
15.54
134,809
2006-04-28
BIIB
Biogen Idec Inc
Sale
8,675
45.17
391,832
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Mullen James C
(CEO & President of Biogen Idec Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
